Full text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Microbes such as the White Spot Syndrome Virus account for severe losses in the shrimp farming industry globally. This review examines the literature on the mangrove plants of Asia and the Pacific with antibacterial, antifungal, or antiviral activities. All of the available data published on this subject were collected from Google Scholar, PubMed, Science Direct, Web of Science, ChemSpider, PubChem, and a library search from 1968 to 2022. Out of about 286 plant species, 119 exhibited antimicrobial effects, and a total of 114 antimicrobial natural products have been identified including 12 with MIC values below 1 µg/mL. Most of these plants are medicinal. The mangrove plants of Asia and the Pacific yield secondary metabolites with the potential to mitigate infectious diseases in shrimp aquaculture.

Details

Title
Antimicrobial Secondary Metabolites from the Mangrove Plants of Asia and the Pacific
Author
Sulaiman, Mazdida 1   VIAFID ORCID Logo  ; Nissapatorn, Veeranoot 2 ; Rahmatullah, Mohammed 3   VIAFID ORCID Logo  ; Paul, Alok K 4 ; Rajagopal, Mogana 5   VIAFID ORCID Logo  ; Rusdi, Nor Azizun 6   VIAFID ORCID Logo  ; Jaya Seelan Sathya Seelan 6   VIAFID ORCID Logo  ; Suleiman, Monica 6   VIAFID ORCID Logo  ; Zakaria, Zainul Amiruddin 7 ; Wiart, Christophe 6 

 Department of Chemistry, Faculty of Science, University of Malaya, Kuala Lumpur 50603, Malaysia 
 School of Allied Health Sciences and World Union for Herbal Drug Discovery (WUHeDD), Walailak University, Nakhon Si Thammarat 80160, Thailand 
 Department of Biotechnology & Genetic Engineering, University of Development Alternative, Dhaka 1207, Bangladesh 
 School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7001, Australia 
 Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur 56000, Malaysia 
 Institute for Tropical Biology & Conservation, University Malaysia Sabah, Kota Kinabalu 88400, Malaysia 
 Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University Malaysia Sabah, Kota Kinabalu 88400, Malaysia 
First page
643
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
16603397
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2728492181
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.